HYFT MindWalk Holdings Corp. IFRS
Pharmaceutical Preparations · Nasdaq · SEC CIK 1715925 · Reporting currency CAD · Fiscal year ends 04/30
Financial factors as of 2026-01-31 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY28.5%
TTM net income YoY73.2%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin60.3%
Operating margin—
Net margin-66.5%
FCF margin-64.8%
EBITDA margin—
Returns
ROE-61.5%
ROA-35.7%
ROIC (approx.)—
Asset turnover0.54x
Leverage & solvency
Liabilities / assets35.4%
Debt / equity0.00x
Current ratio3.74x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.91x
Accruals ratio-3.1%
Payout ratio—
Capex / revenue4.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Unit: CAD | FY2025*2025-04-30 | FY2024*2024-04-30 |
|---|---|---|
| Income statement | ||
| Revenue | 24.52M | 24.52M |
| Cost of revenue | 10.97M | 12.46M |
| Gross profit | 13.55M | 12.05M |
| R&D expense | 4.94M | 4.04M |
| SG&A expense | 14.73M | 15.59M |
| Interest expense | 199,000 | 402,000 |
| Pretax income | -34.27M | -28.70M |
| Income tax | -4.03M | -2.59M |
| Net income | -30.23M | -26.11M |
| EPS (basic) | -0.91 | -1.02 |
| EPS (diluted) | -0.91 | -1.02 |
| Balance sheet | ||
| Cash & equivalents | 10.79M | 3.54M |
| Inventory | 2.10M | 2.14M |
| Current assets | 18.75M | 11.49M |
| PP&E, netmay include right-of-use assets (IFRS) | 15.76M | 16.70M |
| Goodwill | 8.23M | 7.69M |
| Intangibles | 1.07M | 23.56M |
| Total assets | 44.44M | 59.99M |
| Current liabilities | 9.01M | 8.12M |
| Total liabilities | 20.82M | 24.31M |
| Shareholders' equity | 23.63M | 35.68M |
| Shares outstanding | 46.15M | 26.94M |
| Cash flow statement | ||
| Operating cash flow | -6.41M | -3.18M |
| Capital expenditure | 799,000 | 1.40M |
| Free cash flow | -7.21M | -4.58M |
| Investing cash flow | -799,000 | -1.56M |
| Financing cash flow | 14.89M | 1.02M |
| Depreciation & amortization | 5.12M | 5.74M |
| Stock-based compensation | 445,000 | 1.53M |
Free plan shows the latest 2 periods; Pro shows all 6 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· Amounts are in the company's reporting currency, CAD, not USD; the site does no currency conversion.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.